Showing 1–12 of 37 results

ACALAKAST 100mg

Acalabrutinib -100 mg  

APRAHYDRO 500mg

Hydroxyurea 500 Mg

CABOZER-40mg

Carbozantinib Tablets 40mg

CABOZER-60mg

Cabozantinib Tablets 60 Mg

Eltrombo-25

Eltrombopag Olamine 25mg

Eltrombo-50

Eltrombopag Olamine 50mg

Gabakast

Gabapentin Capsules IP 300mg

INDENZA 160

Indenza – 160 mg Composition: Enzalutamide 160mg Therapeutic Class: Androgen Receptor Inhibitor Indenza: Trusted Prostate Cancer Medicine Indenza is widely

Lacoaxis

Lacosamide Tablets 50mg

LAPAKAST 250mg

Lapatinib 250mg

OLABIR 150MG TABLETS

Olabir – 150 mg Composition: Olaprib -150 mg Therapeutic Class: Anti-Neoplastic Olabir: Globally Proven Anti-Cancer Medicine Olabir is the doctor’s

OLABIR 150MG TABLETS OLAPARIB

Ovarian Cancer For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who

Leading the Way in Oral Oncology Care Solutions

We are the largest manufacturer, exporter, and supplier of oral oncology care solutions.

Oral solid dosage forms remain the edge in cancer treatment for maintenance therapy, targeted therapy, and outpatient convenience.

At our state-of-the-art manufacturing facility, we develop more than 30 products focused on treating various cancers, including breast cancer, lung cancer, blood cancer, colorectal cancer, and testicular cancers.

Our oncology oral therapeutics set the benchmark in affordable, high-quality care accessible to all.

Complex Therapeutics Expertise:

We are capable of manufacturing complex therapeutics including:

  • • Modified-release and immediate-release tablets and capsules
  • • Using high-quality excipients and APIs
  • • Ensuring maximum solubility and bioavailability

Front Runners in the Oncology Care Landscape

We manufacture a complete range of oncology oral products, including chemotherapy drugs, immunotherapy drugs, hormonal therapy drugs, and targeted therapy drugs.

Most Prescribed and In-Demand Brands

Our flagship products include:

  • • Dorucin-50
  • • Eltrombo-50
  • • Palbocib-125

Global Leaders in Oncology Care

We have been the largest exporter of oncology oral tablets and capsules, with footprints in more than 20 countries across South east Asia, South America, Africa, and all CIS countries.
We continue to resource the next generation of therapeutics, integrating cutting-edge technologies.